HYPR · Hyperfine, Inc.
$0.89
0.00 (-0.04%)
At close · Aug 14
Market Cap
$94.69M
Shares
106.05M
Hyperfine, Inc. Earnings Call Transcripts
Every quarterly earnings call for Hyperfine, Inc. (HYPR) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲532.9%
$2.35M
−$13.17M
'22 Q3
22-11-10
▲226.6%
$1.42M
$15.87M
'22 Q4
23-03-21
▲74.6%
$2.63M
−$12.16M
'23 Q1
23-05-11
▲120.5%
$3.38M
−$10.64M
'23 Q2
23-08-14
▼0.8%
$2.33M
−$10.76M
'23 Q3
23-11-09
▲88.6%
$2.69M
−$10.68M
'23 Q4
24-03-21
▲25%
$3.29M
−$9.85M
'24 Q1
24-05-13
▲7.4%
$3.63M
−$10.16M
'24 Q2
24-08-08
▲56.4%
$3.64M
−$10.33M
'24 Q3
24-11-12
▼13.6%
$2.32M
−$10.39M
'24 Q4
25-02-11
▼35.1%
$2.14M
−$9.42M
'25 Q1
25-05-13
▼25.8%
$2.70M
−$9.22M
'25 Q2
25-08-13
▼5.7%
$3.44M
−$11.02M
'25 Q3
25-11-13
▲128%
$5.29M
−$5.91M
'25 Q4
26-03-18
▲82.6%
$3.90M
−$8.62M
'26 Q1
26-05-12
LATEST
▲44.8%
$3.90M
−$9.30M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Hyperfine, Inc. Q2 FY2026 Earnings Call
Revenue
$3.90M
▲ 44.8% YoY Diluted EPS
$-0.09
Gross margin
50.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-12
Hyperfine, Inc. Q1 FY2026 Earnings Call
Confident tone
Neurology office business
Hospital and IDN business
Revenue growth and financial performance
Revenue
$3.90M
▲ 82.6% YoY Diluted EPS
$-0.09
Gross margin
50.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-18
Hyperfine, Inc. Q4 FY2025 Earnings Call
Confident tone
Next-generation Swoop system and Optive AI software
Pipeline and deal momentum with IDNs
Financial profile and balance sheet
Revenue
$5.29M*
▲ 128% YoY Gross margin
50.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Hyperfine, Inc. Q3 FY2025 Earnings Call
Confident tone
Hospital vertical (ICUs, ERs, IDNs)
Next-generation subsystem and Optive AI launch
Guidance and 2026 outlook
Revenue
$3.44M
▼ 5.7% YoY Diluted EPS
$-0.14
Gross margin
53.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Hyperfine, Inc. Q2 FY2025 Earnings Call
Confident tone
Next-generation Swoop system launch
Office setting / neurology clinic adoption
Revenue and financial performance
Revenue
$2.70M
▼ 25.8% YoY Diluted EPS
$-0.12
Gross margin
49.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Hyperfine, Inc. Q1 FY2025 Earnings Call
Balanced tone
Office/neurology vertical launch
Next-generation AI-powered image quality and software
International growth and India entry
Revenue
$2.14M
▼ 35.1% YoY Diluted EPS
$-0.12
Gross margin
41.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-11
Hyperfine, Inc. Q4 FY2024 Earnings Call
Positive tone
Office channel expansion
Hospital site expansion
International growth
Revenue
$2.32M*
▼ 13.6% YoY Gross margin
35.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Hyperfine, Inc. Q3 FY2024 Earnings Call
Confident tone
Clinical Studies and Evidence
Swoop System and Portable MRI
AI-Powered Software Innovation
Revenue
$3.64M
▲ 56.4% YoY Diluted EPS
$-0.14
Gross margin
52.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Hyperfine, Inc. Q2 FY2024 Earnings Call
Confident tone
Alzheimer's / ARIA clinical program
Revenue and commercial momentum
New site placements (neurology offices, infusion centers)
Revenue
$3.63M
▲ 7.4% YoY Diluted EPS
$-0.14
Gross margin
49.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Hyperfine, Inc. Q1 FY2024 Earnings Call
Confident tone
International expansion via distributors
ASP and revenue mix variability
Alzheimer's clinical program (Care PMR)
Revenue
$3.29M
▲ 25% YoY Diluted EPS
$-0.14
Gross margin
41.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-21
Hyperfine, Inc. Q4 FY2023 Earnings Call
Positive tone
Alzheimer's opportunity
Revenue growth and 2024 guidance
Gross margin improvement
Revenue
$2.69M*
▲ 88.6% YoY Gross margin
38.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Hyperfine, Inc. Q3 FY2023 Earnings Call
Revenue
$2.33M
▼ 0.8% YoY Diluted EPS
$-0.15
Gross margin
48.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Hyperfine, Inc. Q2 FY2023 Earnings Call
Revenue
$3.38M
▲ 120.5% YoY Diluted EPS
$-0.15
Gross margin
42.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Hyperfine, Inc. Q1 FY2023 Earnings Call
Revenue
$2.63M
▲ 74.6% YoY Diluted EPS
$-0.17
Gross margin
43.8%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-21
Hyperfine, Inc. Q4 FY2022 Earnings Call
Revenue
$1.42M*
▲ 226.6% YoY Gross margin
21.1%
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Hyperfine, Inc. Q3 FY2022 Earnings Call
Revenue
$2.35M
▲ 532.9% YoY Diluted EPS
$-0.19
Gross margin
29.3%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Hyperfine, Inc. Q2 FY2022 Earnings Call
Revenue
$1.53M
▲ 328.2% YoY Diluted EPS
$-0.33
Gross margin
-10.8%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Hyperfine, Inc. Q1 FY2022 Earnings Call
Revenue
$1.51M
▲ 355.9% YoY Diluted EPS
$-0.34
Gross margin
5.6%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-23
Hyperfine, Inc. Q4 FY2021 Earnings Call
Revenue
$436,000*
Gross margin
-103.9%
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Showing 1–20 of 20 earnings calls
Key facts
CIK
1833769
CUSIP
44916K106
13F (30d)
81 filings
80 filers
Visit website
Investor relations